Subrata Sen, Ph.D.

Department of Translational Molecular Pathology, Division of Pathology-Lab Medicine Div

Present Title & Affiliation

Primary Appointment

Del & Dennis McCarthy Distinguished Professor, The University of Texas MD Anderson Center

Professor & Deputy Chair, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Faculty Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX

Adjunct Professor, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX

Dual/Joint/Adjunct Appointment

Professor & Deputy Chair, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Faculty Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX

Education & Training

Degree-Granting Education

1988	The University of Texas MD Anderson Cancer Center, Houston, Texas, US, Chromatin Structure, Post Doctoral Fellow
1980	Center of Advanced Studies in Zoology, College of Science, Banaras Hindu University, Varanasi, IN, Molecular Cytogenetics, Zoology, Ph.D
1974	Center of Advanced Studies in Zoology, College of Science, Banaras Hindu University, Varanasi, IN, Zoology, Cytogenetics as the Elective Subject, M.S
1972	College of Science, Banaras Hindu University, Botany, Zoology, Chemistry, BS, with Honors

Postgraduate Training

1990-1991	Visiting Fellow, University of Illinois College of Medicine (Department of Genetics), Chicago, Illinois
1986-1987	Research Associate, The University of Texas MD Anderson Cancer Center (Department of Molecular Pathology), Houston, Texas
1983-1985	Project Investigator, The University of Texas MD Anderson Cancer Center (Department of Molecular Pathology), Houston, Texas
1982-1983	Postdoctoral Fellowship, The University of Texas MD Anderson Cancer Center (Department of Molecular Pathology), Houston, Texas
1976-1980	Junior Research Fellow, Banaras Hindu University, Banaras
1975-1976	University Research Scholar, Banaras Hindu University, Banaras

Experience & Service

Faculty Academic Appointments

Adjunct Professor, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX, 2009 - 2020

Associate Professor, Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - 2010

Assistant Professor, Division of Pathology and Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1997 - 1999

Associate Biologist, Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1997 - 1998

Assistant Professor, Division of Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1990 - 1997

Assistant Biologist, Division of Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1987 - 1990

Lecturer, Department of Zoology, Banaras Hindu University, Varanasi, 1980 - 1982

Administrative Appointments/Responsibilities

Deputy Department Chair, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present

Other Professional Positions

Member of the Advisory Committee for Chair Search of the Department of Translational Molecular Pathology,, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026

Mid-term Review Committee for Yang Chen, Ph.D. Assistant Professor (Tenure Track). Member, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025

Pre-PTC (ADVANCE) Committee for Suyu Liu, PhD, Associate Professor, Department of Biostatistics, University of Texas MD Anderson Cancer Center. Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024

Progress Review Committee for Balasenthil Seetharaman, Ph.D., Assistant Professor (RFA), Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021

Chair of the Search Committee for the recruitment of Associate Professor in the Department of Translational Molecular Pathology,, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021

Alfred G. Knudson Award Scholarship Fellowship Reviewer, Alfred G. Knudson Award, Houston, TX, 2018

Member, Mini-Symposium Organization Committee, Program of Human and Molecular Genetics, Houston, TX, 2012 - 2014

Program Director, Human and Molecular Genetics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, 2012 - 2014

Schissler Foundation Award Scholarship Fellowship Reviewer, Schissler Foundation Award, Houston, TX, 2011

Schissler Foundation Award Scholarship Fellowhsip Reviewer, Schissler Foundation Award, Houston, TX, 2007

Member of the Advisory Board, Jagadis Bose National Science Talent Search Foundation, Kolkata, India, 2002 - 2010

Extramural Institutional Committee Activities

Member, Strategic Planning Review Committee for the Division of Pathology & Laboratory Medicine, University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2024 - Present

Member, Research Enablement Activities and Conduct Team, Member, University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2020 - Present

Member, Research Leadership Team, Member, University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2020 - Present

Member, Faculty Senate Executive Committee, Member, University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2019 - 2021

Member, The University of Texas MD Anderson Cancer Center Promotions and Tenure Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2021

Member, The University of Texas Graduate School of Biomedical Sciences Academic Standards Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2017

Member, Steering Committee, Program in Human and Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2014 - 2016

Chair, Steering Committee, Program in Human and Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2012 - 2014

Member, Program Coordinating Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2014

Adhoc Member, Institutional Research Grants Review Committee (Basic Science), The University of Texas MD Anderson Cancer Center, 2011 - 2012

Member, Membership Committee, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, 2010 - Present

Member, Faculty Senate Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2017

Member, Membership Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2012

Member, Research Affairs Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, 2007 - 2009

Member, Institutional Research Grants Review Committee (Basic Science), The University of Texas MD Anderson Cancer Center, 2007 - 2009

Member, Written Ph.D. Candidacy Examination Committee, Program in Human and Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2006 - 2007

Member, Faculty Senate Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2007

Member, Faculty Achievement Awards Committee for Education, The University of Texas MD Anderson Cancer Center, 2005

Member, Admissions Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2007

Alternate, Admissions Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2004

Member, Steering Committee, Program in Human and Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2002 - 2008

Chair, Admissions Committee, Program in Human & Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2002 - 2004

Member, Institutional Grant Review Committee, Clinical Research, The University of Texas MD Anderson Cancer Center, 2002 - 2004

Member, Institutional Biosafety Committee, The University of Texas MD Anderson Cancer Center, 2002 - 2003

Member, International Admissions Committee, Program in Human & Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2002

Member, Written Ph.D. Candidacy Examination Committee, Program in Human and Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2002

Member, Written Ph.D. Candidacy Examination Committee, The University of Texas MD Anderson Cancer Center, 2001 - 2002

Chair, Admissions Committee, Program in Human & Molecular Genetics, The University of Texas MD Anderson Cancer Center, 2000 - 2004

Member, Admissions Committee, Program in Human and Molecular Genetics, The University of Texas MD Anderson Cancer Center, 1999 - 2001

Member, Review Committee: Ovarian Cancer Program Grants, The University of Texas MD Anderson Cancer Center, 1999 - 2000

Member, Institutional Biosafety Committee, The University of Texas MD Anderson Cancer Center, 1999 - 2000

Member, Selection Committee, Alfred Knudson Graduate Student Thesis Award, The University of Texas MD Anderson Cancer Center, 1999 - 2000

Member, Specialized Masters Committee, The University of Texas MD Anderson Cancer Center, 1998 - 1999

Member, Curriculum Committee: Program in Human and Molecular Genetics, The University of Texas MD Anderson Cancer Center, 1994 - 2000

Member, Quality Assurance Committee, Division of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, 1994 - 1995

Editorial Activities

Member of Editorial Board, Diagnostics, MDPI, 2025 - Present

Associate Editor, Frontiers in Genetics, 2021 - Present

Editor, Oncology Reports, Spandidos Publications, 2018 - Present

Member of Editorial Review Board, Journal of Cancer Research & Therapy, Noble Research Publishing Group, Scotland, UK, 2012 - Present

Member of Editorial Review Board, Journal of Biomarkers in Drug Development, Sci-Technol Omics Group, USA,, 2012 - Present

Member of Editorial Review Board, Journal of Cancer Research & Therapy, 2012

Member of Editorial Review Board, Journal of Biomarkers in Drug Development, 2012

Member of Editorial Review Board, Hormones & Cancer, 2009

Honors & Awards

2025 - Present	Del & Dennis McCarthy Distinguished Professor
2025	Research Excellence Award, University of Texas M.D. Anderson Cancer Center,
2023	Outstanding Achievement Award-Society of American Asian Scientists in Cancer Research
2014	Distinguished Leadership Recognition as the Program Director of the Human and Molecular Genetics Graduate Program, The University of Texas Graduate School of Biomedical Science
2012 - 2013	Certificate of Appreciation for Outstanding Dedication and Service as the Director of the Human and Molecular Genetics Program, The University of Texas Graduate School of Biomedical Scienc
2010	Featured on the Wall of Science for Publication in the Journal Cancer Cell, University of Texas MD Anderson Cancer Center
1999	Recognized as a member of the "M. D. Anderson Brightest Stars" on the Day of Science
1985	Rosalie B. Hite Fellowship Merit Award for Postdoctoral Research, The University of Texas M.D. Anderson Cancer Center
1982	Fulbright Travel Award for Postdoctoral Research from the United States Information Agency, The University of Texas M.D. Anderson Cancer Center

Selected Presentations & Talks

Local Presentations

2025. Transcriptomic and Proteomic Biomarkers in Extracellular Vesicles as Biomarkers of Oncogenic Mutations in Pancreatic Cystic Lesions. Division of Pathology & Laboratory Medicine Annual Research Symposium, UT MD Anderson Cancer Center. Houston, Texas, US.
2024. Oncogenic KRAS promotes SRSF1-mediated miRNA sorting in extracellular vesicles circulating in pancreatic cyst fluid. 11th Annual Translational Molecular Pathology Retreat, UT MD Anderson Cancer Center,. Houston, Texas, US.
2022. Deciphering the mechanism of regulation of SH3D19 by miRNA mediated network in pancreatic cancer. 9th Annual Translational Molecular Pathology Retreat, UT MD Anderson Cancer Center,. Houston, Texas, US.
2020. Atlas of Circulating miRNAs from Small Volume Plasma as Liquid Biopsy Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma. 10th Annual Translational Molecular Pathology Retreat, UT MD Anderson Cancer Center,. Houston, Texas, US.
2020. Epigenetically elevated expression of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer. 9th Annual Translation Molecular Pathology Retreat, UT MD Anderson Cancer Center, Houston. Houston, Texas, US.
2017. Targeting Aurora-A-PLK1 Pathways in Small Cell Lung Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2014. Challenges and Opportunities in Early Detection of Pancreatic Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2014. Targeted Key Pathways in Triple Negative Breast Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2014. Challenges and Opportunities in Early Detection of Pancreatic Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2014. Mitosis Regulatory and Cancer Causing Genes: Molecular Mechanisms of Their Unholy Alliance. Conference. The University of Texas Health Science Center of Houston. Houston, TX, US.
2014. Characterization of Aurora-A pVHL Functional Interaction Pathways as a Therapeutic Target of Clear Cell Renal Cell Carcinoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2013. Chromosome 20 Genomics to Cancer Biomarkers. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2011. Deciphering microRNA Regulated Networks for Biomarkers in Pancreatic Cancer. Conference. The Univeristy of Texas MD Anderson Cancer Center. Houston, TX, US.
2009. Mitotic Checkpoint Signaling Pathway as a Therapeutic Target in Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2007. Aurora Kinase Regulation of Chromosome Segregation; Is This an Epigenic Target for Therapy?. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2007. Spindle Checkpoint Pathway and Chromosomal Instability in Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2006. Chromosomal Instability in Cancer: Lesson Learned from Aurora Kinases. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2006. Mitotic Syphony Turning Into Cancer Chaos; Role of Aurora Kinases. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2005. Aurora Kinases as Novel Therapeutic Targets - Promise & Paradox. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.

National Presentations

2026. RASH3D19 mediates RAS pathway activation and adaptive resistance to KRAS targeting drugs in cancer. AACR Annual Meeting. Houston, Texas, US.
2024. Spatial Analysis reveals differential immune cell interactions in Histologic Progression areas of Intraductal Papillary Mucinous Neoplasms of the Pancreas, Society of Immunotherapy of Cancer Annual Meeting. Houston, Texas, US.
2022. Hyaluronic acid in extracellular vesicles fuels an immunosuppressive monocyte landscape in pancreatic cancer. Gordon Conference on Proteoglycans,. Houston, Texas, US.
2022. Epigenetic activation of SOX11 is associated with recurrence and progression of DCIS to invasive breast cancer. AACR Special Conference: Rethinking DCIS: An Opportunity for Prevention? Philadelphia, PA, US,.
2019. Cancer Moonshot Collaborative Meeting – PaCMEN (Moderator). Conference. Workshop: Bioconductor and Beyond. Bethesda, MD, US.
2019. Next Gen Biomarkers. Invited. 11th NCI-EDRN Scientific Workshop. Bethesda, MD, US.
2019. AACR-Pancreatic Cancer: Advances in Science and Clinical Care. Invited. American Association for Cancer Research. Boston, MA, US.
2019. Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy. Invited. 34th Aspen Cancer Conference. Aspen, CO, US.
2019. Annual Meeting. Invited. American Associatoin for Cancer Research. Atlanta, GA, US.
2018. Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy. Invited. 33rd Aspen Cancer Conference. Aspen, CO, US.
2018. Annual Meeting. Invited. American Association for Cancer Research. Chicago, IL, US.
2017. Mechanisms of Toxicity Carcinogenesis, Cancer Prevention & Cancer Therapy. Invited. 32nd Aspen Cancer Conference. Aspen, CO, US.
2017. Precancer Atlas Initiative Think Tank Committee. Invited. National Cancer Institute. Rockville, MD, US.
2016. Mechanisms of Toxicity Carcinogenesis, Cancer Prevention & Cancer Therapy. Invited. 31st Aspen Cancer Conference. Aspen, CO, US.
2015. Mechanisms of Toxicity Carcinogenesis, Cancer Prevention & Cancer Therapy. Invited. 30th Aspen Cancer Conference. Aspen, CO, US.
2014. Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy. Invited. 29th Aspen Cancer Conference. Aspen, CO, US.
2014. EDRN Scientific Worshop. Invited. 27th National Cancer Institute Early Detection Research Network Steering Committee Meeting. Houston, TX, US.
2013. EDRN Scientific Workshop. Invited. 26th National Cancer Institute Early Detection Research Network Steering Committee Meeting. Seattle, WA, US.
2013. Mechanisms of Toxicity Carcinogenesis, Cancer Prevention & Cancer Therapy. Invited. 28th Aspen Cancer Conference. Aspen, CO, US.
2013. The Endoctrine Society. Invited. 95th Annual Meeting and Expo. San Francisco, CA, US.
2013. 8th EDRN Scientific Workshop. Invited. National Cancer Institute Early Detection Research Network Steering Committee Meeting. Bethesda, MD, US.
2012. EDRN Scientific Workshop. Invited. 25th National Cancer Institute Early Detection Research Network Steering Committee Meeting. San Antonio, TX, US.
2012. Mechanisms of Toxicity Carcinogenesis, Cancer Prevention & Cancer Therapy. Invited. 27th Aspen Cancer Conference. Aspen, CO, US.
2012. EDRN Scientific Workshop. Invited. 24th National Cancer Institute Early Detection Research Network Steering Committee Meeting. Tempe, AZ, US.
2012. Aurora Kinase Regulation and VHL. Invited. 10th Internatinoal VHL Medical Conference. Houston, TX, US.
2011. 7th EDRN Scientific Workshop. Invited. 23rd National Cancer Institute Early Detection Research Network Steeting Committee Meeting. Herndon, VA, US.
2011. Mechanisms of Toxicity Carcinogenesis, Cancer Prevention & Cancer Therapy. Invited. 26th Aspen Cancer Conference. Aspen, CO, US.
2011. MicroRNA and Early Detection. Invited. 22nd National Cancer Institute Early Detection Research Network Steering Committee Meeting. Los Angeles, CA, US.
2010. Imaging Interest Group. Invited. National Cancer Institute Early Detection Research Network Steering Committee Meeting. Dallas, TX, US.
2009. Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy. Invited. 24th Aspen Cancer Conference. Aspen, CO, US.
2008. Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy. Invited. 23rd Aspen Cancer Conference. Aspen, CO, US.
2007. Aurora Kinase A is a Key Regulator of Kinetochore Associated Microtubule Formation in Mammalian Cells. Invited. FASEB Summer Research Conferences. Indian Wells, CA, US.
2006. The Aurora Family of Kinases: A,B,C's of Mitosis in Human Cells. Invited. 21st Aspen Cancer Conference. Aspen, CO, US.
2004. Title not provided. Invited. “Aneuploidy and Cancer: clinical and experimental aspects”. San Francisco, US.
1998. Title not provided. Invited. Fifty-first Annual symposium on Fundamental Cancer Research: Molecular Targets for Cancer Therapy and Prevention, US.
1996. Title not provided. Invited. "Gordon Research Conference on ""Chemotherapy of Experimental and Clinical Cancer”". Oxford.
1995. Title not provided. Invited. Gordon Research Conference on “Cancer”, US.
1995. Isolation of chromosome region specific FISH probes and expressed sequence clones by microdissection. Invited. Vysis, Inc. Downers Grove, IL, US.
1995. Title not provided. Invited. Colloquium at the Division of Cancer Prevention & Control at the National Cancer Institute, US.
1994. Title not provided. Invited. Second SPORE Investigators Meeting. Rockville, MD, US.
1988. Title not provided. Invited. FASEB Summer Research Conference on Somatic Cell Genetics, VT, US.
1987. . Invited. FASEB Summer Research Conference on Somatic Cell Genetics, VT, US.

International Presentations

2018. . Invited. Asian Forum of Chromosome and Chromatin Biology. Bangalore, IN.
2013. p63/p73. Invited. 6th International p63/p73 Workshop. Chiba, JP.
2012. Genomics and Community Health. Invited. 38th Annual Conference of the ISHG of Human Genetics. Varanasi, IN.
2012. Genomics and Community Health. Invited. International Symposium on Development and Complex Disorders, IN.
2012. International Workshop on Ataxia-Telangiectasia. Invited. ATW 2012 Workshop. Delhi, IN.
2012. Workshop on Translational Cancer Prevention and Biomarkers. Invited. National Cancer Institute, USA - ICMR, India. Bangalore, IN.
2011. Recent Developments in Cancer Prevention. Invited. Fourth International Conference on Translational Cancer Research. Udaipur, IN.
2011. Pathway targeting microRNA signature as biomarkers in cancer. Invited. NCI, USA - ICMR, India, IN.
2010. Aurora Kinases in Chromosome Biology and Malignant Transformation. Invited. Asian Forum of Chromosome and Chromatin Biology. Bangalore, IN.
2010. Functional Genomics. Invited. Internaional Symposium on Functional Genomics. Varanasi, IN.
2010. Hormonal Oncogenesis. Invited. Sixth International Symposium. Tokyo, JP.
2009. Cell Signaling and Cancer Therapy. Invited. International Symposium on Translational Cancer Research. Bhubanishwar, IN.
2009. Emerging Challenges and Approaches in Cancer Biology. Conference. IACR Annual Convention. Bangalore, IN.
2008. Genetics Revised: The Genomics and Proteomics Advantage. Invited. ISHG International Symposium. Visakhapatnam, IN.
2006. Genetic Disorders: Focus on Hemoglobinopathies. Invited. Indo-US Symposium. Varanasi, IN.
2006. Functional Significance of Aurora Kinase A in Centrosome Amplification & Genomic Instability. Invited. 5th International Symposium on Hormonal Carcinogenesis. Montpellier, FR.
2005. Title not provided. Invited. Annual Convention of the Indian Association for Cancer Research and International Symposium on Human Papillomavirus and Cervical Cancer. Noida, IN.
2004. Title not provided. Invited. “International Conference on Human Genome Update”. Hyderabad, IN.
2004. Title not provided. Invited. First International Symposium on “Cellular Response to Genomic Damage and Chromatin dynamics”. Hiroshima, JP.
2004. Title not provided. Invited. Annual meeting of the Indian Society of Human Genetics. Bangalore, IN.
1995. Title not provided. Invited. 5th International Conference of Anticancer Research. Corfu, GR.
1994. Title not provided. Invited. American Association for Cancer Research Special Conference on Cancer: Perturbations in Cell Cycle Control and Genomic Integrity. Banff, CA.
1983. Chromosome. Invited. 8th International Chromosome Conference. Lubeck, DE.

Formal Peers

2019. MCL PCA SMART 3 SEQ Data to JPL. Invited. San Diego, CA, US.
2018. Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer. Invited. Bethesda, MD, US.
2018. Molecular Profiling of Cystic Fluid for Improved Evaluation of Pancreatic Cysts. Invited. Baltimore, MD, US.
2018. N/A. Invited. Bethesda, MD, US.
2017. N/A. Invited. Los Angeles, CA, US.
2017. N/A. Invited. Houston, TX, US.
2016. N/A. Invited. Burlington, VT, US.
2011. Chromosomal Instability and microRNA Dysregulation in Cancer: From Biology to Biomarker Discovery. Invited. Baltimore, MD, US.
2011. Chromosomal Instability in Cancer: Role of Aurora Kinases. Invited. Houston, TX, US.
2005. Saban Research Institute, Children’s Hospital. Invited. Los Angeles, CA, US.
2004. Baylor College of Medicine. Invited. Houston, TX, US.
2004. Molecular Pharmacology & Experimental Therapeutics Seminar Series. Invited. Rochester, MN, US.
2004. University of Maryland Medical School. Invited. Baltimore, MD, US.
1996. Microdeletion Syndromes. Invited, US.
1996. Apoptosis and Drug Resistance. Invited. Houston, TX, US.
1995. Chromosome Microdissection. Invited. Buffalo, NY, US.
1995. Chromosome Microdissection. Invited. Houston, TX, US.

Less

Grant & Contract Support

Date:	2026 - 2029
Title:	Biology of RASH3D19 in PDAC Development and Therapeutic Resistance
Funding Source:	CANCER PREVENTION RESEARCH INST OF TX
Role:	PI

Date:	2026 - 2029
Title:	Drug targeting of RASH3D19 in mutant KRAS cancers
Funding Source:	CANCER PREVENTION RESEARCH INST OF TX
Role:	PI

Date:	2026 - 2031
Title:	Optimizing Pre-analytical Variables in Cytologic Liquid Biopsy Specimens for Clinical Biomarker Assays
Funding Source:	NIH
Role:	PI

Date:	2024 - 2029
Title:	Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	U01CA214263-01A1

Date:	2022 - 2029
Title:	Translational Genomics and Precision Medicine in Cancer Training Program
Funding Source:	NIH
Role:	PI

Date:	2022 - 2027
Title:	PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming Consortium coordination, Data Management and Education)
Funding Source:	NIH
Role:	PI

Date:	2020 - 2025
Title:	Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples
Funding Source:	NIH/NCI
Role:	PI

Date:	2019 - 2022
Title:	Predictive Biomarkers of DCIS to Invasive Breast Cancer Progression
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	RP 190037

Date:	2018 - 2020
Title:	Nanoplasmonic Molecular Profiling of Pancreatic Cyst Fluid Exosomes for Early Detection of Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	R21

Date:	2018 - 2021
Title:	Blood-Based Biomarkersfor the Early Detection of Pancreatic Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI
ID:	RP 180607

Date:	2017 - 2020
Title:	A Pre-Cancer Atlas (PCA) for Breast, Lung, Pancreas and Prostate
Funding Source:	NIH/NCI
Role:	Co-I
ID:	3 U01 CA196403-03S1

Date:	2016 - 2019
Title:	Early Detection of Pancreatic Cancer
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Project Leader

Date:	2015 - 2020
Title:	Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1 U01 CA196403-01

Date:	2015 - 2018
Title:	Pancreatic Cyst Fluid miRNOME for Biomarkers of Pancreatic Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	1 R21 CA185962-01A1

Date:	2014 - 2017
Title:	Biomarkers for the Early Detection of Pancreatic Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	U01 CA111302-10

Date:	2013 - 2014
Title:	Aurora A-p53 Family Protein Regulatory Circuits in Cancer: Novel Therapeutic Targets
Funding Source:	The University of Texas M.D. Anderson Cancer Center
Role:	PI

Date:	2013 - 2015
Title:	Characterization of Aurora-A-pVHL Functional interaction Pathway as a Therapeutic Target of ccRCC
Funding Source:	The University of Texas M.D. Anderson Cancer Center
Role:	PI

Date:	2011 - 2012
Title:	Subcontract from the University of Maryland to validate Plasma miRNA and protein biomarkers for early detection of pancreatic cancer
Funding Source:	University of Maryland - Baltimore
Role:	PI
ID:	91011269

Date:	2011 - 2012
Title:	Pre-validation and Validation of Pancreatic Ductal Adenocarcinoma Associated MicroRNA Networks in Exocrine Pancreatic Secretions and Blood
Funding Source:	University of Maryland - Baltimore
Role:	PI

Date:	2010 - 2012
Title:	Genetic Pathways of Chromosomal Instability in Cancer: Identification of Novel Biomarkers and Therapeutic Targets
Funding Source:	The University of Texas M.D. Anderson Cancer Center
Role:	PI
ID:	30026164

Date:	2010 - 2015
Title:	Biomarkers For The Early Detection Of Pancreatic Cancer
Funding Source:	NIH/NCI
Role:	PI
ID:	U01 CA111302 07

Date:	2010 - 2015
Title:	Aurora-A/BTAK/STK15 Oncoprotein in Mitotic Spindle Assembly and Checkpoint Response
Funding Source:	NIH/NCI
Role:	PI
ID:	R01-CA089716-07

Date:	2010 - 2012
Title:	Functional Screening of Oncogenic MicroRNA Targets in Mutant Ras Expressing Pancreatic Cancer
Funding Source:	The University of Texas M.D. Anderson Cancer Center
Role:	PI
ID:	80094724

Date:	2004 - 2009
Title:	Biomarkers for the early detection of pancreatic cancer
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	U01 CA111302 05

Date:	2001 - 2003
Title:	STK15/BTAK and Centrosome Anomaly in Human Breast Cancer
Funding Source:	DOD
Role:	PI
ID:	DAMD17-01-1-0302-1

Date:	2001 - 2007
Title:	Novel human oncogene STK15/BTAK/Aurora 2
Funding Source:	NIH
Role:	PI
ID:	NIH RO1 CA66723

Date:	2000 - 2004
Title:	STK15/Aurora 2 kinase in centrosome biogenesis and function
Funding Source:	Pharmarcia Research Grant Award
Role:	PI
ID:	SR00-209

Date:	1999 - 2004
Title:	Early detection of urinary bladder cancer
Funding Source:	NIH
Role:	Co-PI
ID:	UOICA 85078

Selected Publications

Peer-Reviewed Articles

Treekitkarnmongkol, W, Katayama, H, Sankaran, D, Tai, MC, Rauth, S, Chen, H, Nguyen, T, Kobayashi, K, Thege, F, Ponnusamy, MP, Batra, SK, Wang, H, Wistuba, II, Schmittgen, TD, Heymach, JV, Kopetz, S, Hu, T, Yao, W, Maitra, A, Sen, S. RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer. Nature cell biology 28(1):197-206, 2026. e-Pub 2026. PMID: 41326795.
Jones, JC, Hegde, A, Huang, YJ, Manyam, GC, Srivastava, V, Song, JH, Cheng, Y, Krahe, R, Treekitkarnmongkol, W, Meltzer, SJ, Kopetz, S, Hamilton, SR, Katayama, H, Sen, S. Chromosome 20q gene signature associated with colorectal cancer progression. Oncology reports 54(4), 2025. e-Pub 2025. PMID: 40682849.
Maher, MH, Treekitkarnmongkol, W, Ghatak, S, Dai, J, Liu, S, Nguyen, T, Duose, D, Kim, M, Hu, T, Hurd, MW, Paris, PL, Kirkwood, K, Maitra, A, Luthra, R, Sen, S, Roy Chowdhuri, S. An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid. Cancer Cytopathology 133(4), 2025. e-Pub 2025. PMID: 40106268.
Yang, S, Tang, W, Azizian, A, Gaedcke, J, Ohara, Y, Cawley, H, Hanna, N, Ghadimi, MB, Lal, T, Sen, S, Creighton, CJ, Gao, J, Putluri, N, Ambs, S, Hussain, P. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways. Carcinogenesis 45(8):582-594, 2024. e-Pub 2024. PMID: 38629149.
Yang, S, Tang, W, Azizian, A, Gaedcke, J, Ohara, Y, Cawley, H, Hanna, N, Ghadimi, MB, Lal, T, Sen, S, Creighton, CJ, Gao, J, Putluri, N, Ambs, S, Hussain, P. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways. Carcinogenesis 45(8):582-594, 2024. e-Pub 2024. PMID: 38629149.
Treekitkarnmongkol, W, Shah, V, Kai, K, Katayama, H, Wong, J, Ladha, FA, Nguyen, T, Menegaz, BA, Lu, W, Yang, F, Mino, B, Tang, X, Gagea Iurascu, M, Batra, H, Raso, G, Wistuba, II, Krishnamurthy, S, Pinder, SE, Sawyer, EJ, Thompson, A, Sen, S. Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer. British journal of cancer 131(1):171-183, 2024. e-Pub 2024. PMID: 38760444.
Treekitkarnmongkol, W, Dai, J, Liu, S, Sankaran, D, Nguyen, T, Balasenthil, S, Hurd, MW, Chen, M, Katayama, H, Roy-Chowdhuri, S, Calin, GA, Brand, RE, Lampe, PD, Hu, T, Maitra, A, Koay, EJ, Killary, AM, Sen, S. Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. Gastro Hep Advances 3(8):1098-1115, 2024. e-Pub 2024. PMID: 39529638.
Treekitkarnmongkol, W, Solis Soto, LM, Sankaran, D, Gagea Iurascu, M, Singh, P, Mistry, R, Nguyen, T, Kai, K, Liu, J, Sasai, K, Jitsumori, Y, Liu, J, Nagao, N, Stossi, F, Mancini, MA, Wistuba, II, Thompson, AM, Lee, JM, Cadiñanos, J, Wong, KK, Abbott, CM, Sahin, AA, Liu, S, Katayama, H, Sen, S. eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer. Science Signaling 17(826), 2024. e-Pub 2024. PMID: 38442201.
Balasenthil, S, Liu, S, Dai, J, Bamlet, WR, Petersen, GM, Chari, ST, Maitra, A, Chen, N, Sen, S, McNeill Killary, A. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. Clinica Chimica Acta 551, 2023. e-Pub 2023. PMID: 37774897.
Semaan, A, Bernard, V, Wong, J, Makino, Y, Swartzlander, DB, Rajapakshe, K, Lee, JJ, Officer, A, Schmidt, CM, Wu, HH, Scaife, CL, Affolter, K, Nachmanson, D, Firpo, MA, Yip-Schneider, MT, Lowy, AM, Harismendy, O, Sen, S, Maitra, A, Jakubek Swartzlander, Y, Guerrero, PA. Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms. Cancer Research Communications 3(10):2062-2073, 2023. e-Pub 2023. PMID: 37721516.
Purushothaman, A, Oliva-Ramirez, J, Treekitkarnmongkol, W, Sankaran, D, Hurd, MW, Putluri, N, Maitra, A, Haymaker, CL, Sen, S. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. International journal of molecular sciences 24(19), 2023. e-Pub 2023. PMID: 37834100.
Purushothaman, A, Oliva-Ramirez, J, Treekitkarnmongkol, W, Sankaran, D, Hurd, MW, Putluri, N, Maitra, A, Haymaker, CL, Sen, S. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. International journal of molecular sciences 24(19), 2023. e-Pub 2023. PMID: 37834100.
Thaiparambil, J, Amara, CS, Sen, S, Putluri, N, El-Zein, R. Cigarette smoke condensate induces centrosome clustering in normal lung epithelial cells. Cancer medicine 12(7):8499-8509, 2023. e-Pub 2023. PMID: 36621828.
Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Cancer Prev Res (Phila) 14(7):729-740, 2021. e-Pub 2021. PMID: 33893071.
Das SS, Sen S, Zaman RU, Biswas RN. Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments. J Hematol Blood Transfus, 2021. e-Pub 2021.
Kode J, Kovvuri J, Nagaraju B, Jadhav S, Barkume M, Sen S, Kasinathan NK, Chaudhari P, Mohanty BS, Gour J, Sigalapalli DK, Kumar CG, Pradhan T, Banerjee M, Kamal A. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors. Bioorg Chem, 2020. e-Pub 2020. PMID: 33207276.
Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, De Los Santos MC, Anfossi S, Shimizu M, Shah MY, Ling H, Shen P, Multani AS, Pardini B, Burks JK, Katayama H, Reineke LC, Huo L, Syed M, Song S, Ferracin M, Oki E, Fromm B, Ivan C, Bhuvaneshwar K, Gusev Y, Mimori K, Menter D, Sen S, Matsuyama T, Uetake H, Vasilescu C, Kopetz S, Parker-Thornburg J, Taguchi A, Hanash SM, Girnita L, Slaby O, Goel A, Varani G, Gagea M, Li C, Ajani JA, Calin GA. The Long Noncoding RNA CCAT2 induces chromosomal instability through BOP1 - AURKB signaling. Gastroenterology. e-Pub 2020. PMID: 32805281.
Kholiya F, Chatterjee S, Bhojani G, Sen S, Barkume M, Kasinathan NK, Kode J, Meena R. Seaweed polysaccharide derived bioaldehyde nanocomposite: Potential application in anticancer therapeutics. Carbohydr Polym 240:116282, 2020. e-Pub 2020. PMID: 32475566.
Dutta P, Pando SC, Mascaro M, Riquelme E, Zoltan M, Zacharias NM, Gammon ST, Piwnica-Worms D, Pagel MD, Sen S, Maitra A, Shams S, McAllister F, Bhattacharya PK. Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy. Int J Mol Sci 21(10), 2020. e-Pub 2020. PMID: 32466260.
Dutta P, Perez MR, Lee J, Kang Y, Pratt M, Salzillo TC, Weygand J, Zacharias NM, Gammon ST, Koay EJ, Kim M, McAllister F, Sen S, Maitra A, Piwnica-Worms D, Fleming JB, Bhattacharya PK. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. J Proteome Res 18(7):2826-2834, 2019. e-Pub 2019. PMID: 31120258.
Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA. Single Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. Clin Cancer Res 25(7):2194-2205, 2019. e-Pub 2019. PMID: 30385653.
Jiao L, Maity S, Coarfa C, Rajapakshe K, Chen L, Jin F, Putluri V, Tinker LF, Mo Q, Chen F, Sen S, Sangi-Hyghpeykar H, El-Serag HB, Putluri N. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prev Res (Phila) 12(4):237-246, 2019. e-Pub 2019. PMID: 30723176.
Kai K, Iwamoto T, Zhang D, Shen L, Takahashi Y, Rao A, Thompson A, Sen S, Ueno NT. CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer. Sci Rep 8(1):9427, 2018. e-Pub 2018. PMID: 29930294.
Balasenthil B, Huang Y, Liu S, Marsh T, Chen J, Stass SA, KuKuruga D, Brand R, Chen N, Frazier ML, Lee J, Srivastava S, Sen S, Killary AM. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. J Natl Cancer Inst 109:8, 2017. e-Pub 2017. PMID: 28376184.
Treekitkarnmongkol W, Katayama H, Kai K, Sasai K, Jones JC, Wang J, Shen L, Sahin AA, Gagea M, Ueno NT, Creighton CJ, Sen S. Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. Carcinogenesis 37(12):1180-1189, 2016. e-Pub 2016. PMID: 27624071.
Chen J, Wu X, Huang Y, Chen W, Brand RE, Killary AM, Sen S, Frazier ML. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Oncotarget 7(35):56480-56490, 2016. e-Pub 2016. PMID: 27486767.
Sasai K, Katayama H, Hawke DH, Sen S. Aurora-C Interactions with Survivin and INCENP Reveal Shared and Distinct Features Compared with Aurora-B Chromosome Passenger Protein Complex. PLoS One 11(6):e0157305, 2016. e-Pub 2016. PMID: 27332895.
Kai K, Kondo K, Wang X, Xie X, Pitner MK, Reyes ME, Torres-Adorno AM, Masuda H, Hortobagyi GN, Bartholomeusz C, Saya H, Tripathy D, Sen S, Ueno NT. Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases. Mol Cancer Ther 14(12):2687-99, 2015. e-Pub 2015. PMID: 26443806.
Fujii S, Srivastava V, Hegde A, Kondo Y, Shen L, Hoshino K, Gonzalez Y, Wang J, Sasai K, Ma X, Katayama H, Estecio MR, Hamilton SR, Wistuba I, Issa JP, Sen S. Regulation of AURKC expression by CpG island methylation in human cancer cells. Tumour Biol 36(10):8147-58, 2015. e-Pub 2015. PMID: 25990457.
Wang J, Yin H, Panandikar A, Gandhi V, Sen S. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug. Int J Oncol 47(2):782-90, 2015. e-Pub 2015. PMID: 26058363.
Wang J, Paris PL, Chen J, Ngo V, Yao H, Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, Bondada S, Kirkwood K, Sen S. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. Cancer Lett 356(2 Pt B):404-9, 2015. e-Pub 2015. PMID: 25304377.
Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLoS One 10(10):e0139049, 2015. e-Pub 2015. PMID: 26431551.
Srivastava V, Sen S. Genetic variation in coding region of Aurora kinase A gene leads to cancer susceptibility. Cancer Epidemiol 38(2):109-10, 2014. e-Pub 2014. PMID: 24685408.
Wang J, Zang KY, Liu SM, Sen S. Tumor Associated Circulating MicroRNAs as Biomarkers of Cancer. Molecules 19:1912-1938, 2014. e-Pub 2014. PMID: 24518808.
Huang J, Wang J, Srivastava V, Sen S, Liu S. MicroRNA Machinery Genes as Novel Biomarkers for Cancer. Frontiers in Oncology, 2014. e-Pub 2014.
Wang J, Raimondo M, Guha S, Chen J, Diao L, XDong X, Wallace MB, Killary AM, Frazier ML, Woodward TA, Sen S. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer, 2014. e-Pub 2014.
Chen N, Balasenthil S, Reuther J, Frayna A, Wang Y, Chandler DS, Abruzzo LV, Rashid A, Rodriguez J, Lozano G, Cao Y, Lokken E, Chen J, Frazier ML, Sahin AA, Wistuba II, Sen S, Lott ST, Killary AM. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition. Cancer Discov 3(10):1172-89, 2013. e-Pub 2013. PMID: 23838884.
Ling H, Spizzo R, Atlasi Y Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafa' R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, et al SS. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res 23(9):1446-1461, 2013. e-Pub 2013.
Yang G, Mercado-Uribe I, Multani S, Sen S, Shih IM, Wong KK, Gershenson DM, Lui J. Ras promotes tumorgenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinasis. International J. Cancer 133(2):275-285, 2013. e-Pub 2013.
Liu Q, Chen J, Wang J, Amos C, Killary AM, Sen S, Wei C, Frazier ML. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol Carcinog, 2013. e-Pub 2013.
Qi J, Wang J, Katayama H, Sen S, Liu SM. Circulating microRNAs (cmRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma 60(2):135-142, 2013. e-Pub 2013.
Torchia EC, Zhang L, Huebner AJ, Sen S, Roop DR. Aurora Kinase-A Dificiency During Skin Development Impairs Cell Division and Stratification. J. Invest Dermatol 133:78-86, 2012. e-Pub 2012.
Liu Q, Chen J, Mai B, Amos C, Killary AM, Sen S, Wei C, Frazier ML. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in caucasians. Mol Carcinog 51(5):433-8, 2012. e-Pub 2012.
Katayama H, Wang J, Treekitkarnmongkol W, Kawai H, Sasai K, Zhang H, Wang H, Adams HP, Jiang S, Chakraborty SN, Suzuki F, Arlinghaus RB, Liu J, Mobley JA, Grizzle WE, Wang H, Sen S. Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell 21(2):196-211, 2012. e-Pub 2012.
Derenzini E, Lemoine M, Buglio D, Katayama H, Ji Y, Davis RE, Sen S, Younes A. The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma. Blood Cancer J 12(46), 2011. e-Pub 2011.
Wang J, Sen S. MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease. J Biosci 36(3):481-491, 2011. e-Pub 2011.
Chen J, Wu X, Pande M, Amos CI, Killary AM, Sen S, Frazier ML. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas 40(6):872-875, 2011. e-Pub 2011. PMID: 21697764.
Katayama H, Sen S. Functional Significance of Aurora Kinase A Regulatory Interactions with p53-ERα Complex in Human Breast Cancer Cells. Horm Cancer 2(2):117-124, 2011. e-Pub 2011.
Balasenthil S, Chen N, Lott ST, Chen J, Carter J, Grizzle WE, Frazier ML, Sen S, Killary AM. A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Cancer Prev Res (Phila) 4(1):137-49, 2011. e-Pub 2011.
Katayama H, Sen S. Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta 1799(10-12):829-839, 2010. e-Pub 2010.
Molli PR, Li DQ, Bagheri-Yarmand R, Pakala SB, Katayama H, Sen S, Iyer J, Chernoff J, Tsai MY, Nair SS, Kumar R. Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A. J Cell Biol 190(1):101-114, 2010. e-Pub 2010. PMID: 20603326.
Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, Wang H, Sen S, Hung MC, Mills GB, Chang S, Multani AS, Mercado-Uribe I, Liu J. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 16(12):3171-3181, 2010. e-Pub 2010. PMID: 20423983.
Jiang S, Katayama H, Wang J, Li SA, Hong Y, Radvanyi L, Li JJ, Sen S. Estrogen-induced aurora kinase-A (AURKA) gene expression in activated by GATA-3 in estrogen receptor-positive breast cancer cells. Horm Cancer 1(1):11-20, 2010. e-Pub 2010.
Frenkel M, Mishra BM, Sen S, Yang P, Pawlus A, Vence L, Leblanc A, Cohen L, Banerji P, Banerji P. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 36(2):395-403, 2010. e-Pub 2010.
Chen J, Amos CI, Merriman KW, Wei Q, Sen S, Killary AM, Frazier ML. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Pancreas 39(1):1-4, 2010. e-Pub 2010. PMID: 19910837.
Zhu J, Sen S, Wei C, Frazier ML. Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription. Int J Oncol 36(1):39-48, 2010. e-Pub 2010.
Sen S. Aurora-C: the youngest of "the three (Aurora kinase) tenors" of mitotic symphony. Cell Cycle 8(19):3076-7, 2009. e-Pub 2009.
Torchia EC, Chen Y, Sheng H, Katayama H, Fitzpatrick J, Brinkley WR, Caulin C, Sen S, Roop DR. A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors. Cancer Res 69(18):7207-7215, 2009. e-Pub 2009. PMID: 19738056.
Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM, Sen S. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2(9):807-813, 2009. e-Pub 2009.
Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence free survival in early onset breast cancer. PLoS Med 6(5):e1000068, 2009. e-Pub 2009. PMID: 19536326.
Mazumdar A, Henderson YC, El-Naggar AK, Sen S, Clayman GL. Aurora Kinase A Inhibition and Paclitaxel as Targeted Combination Therapy for Head and Neck Squamous Cell Carcinoma. Head Neck 31(5):625-34, 2009. e-Pub 2009. PMID: 19107951.
Chen J, Li D, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol 16(2):431-9, 2009. e-Pub 2009.
Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. Cancer Lett 272(1):32-9, 2008. e-Pub 2008.
Park HS, Park WS, Bondaruk J, Tanaka N, Katayama H, Lee S, Spiess PE, Steinberg JR, Wang Z, Katz RL, Dinney C, Elias KJ, Lotan Y, Naeem RC, Baggerly K, Sen S, Grossman HB, Czerniak B. Quantitation of Aurora Kinase a gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst 100(19):1401-1411, 2008. e-Pub 2008. PMID: 18812553.
Katayama H, Sasai K, Kloc M, Brinkley BR, Sen S. Aurora kinase-A regulates kinetochore/chromatin associated microtubule assembly in human cells. Cell Cycle 7(17):2691-704, 2008. e-Pub 2008.
Sasai K, Parant JM, Brandt ME, Carter J, Adams HP, Stass SA, Killary AM, Katayama H, Sen S. Targeted disruption of Aurora-A causes abnormal mitotic spindle assembly, chromosome misalignment and embryonic lethality. Oncogene 27(29):4122-4127, 2008. e-Pub 2008.
Katayama H, Sasai K, Czerniak BA, Carter JL, Sen S. Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex. J Cell Biochem 102(5):1318-1331, 2007. e-Pub 2007.
Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res 13(10):3100-3104, 2007. e-Pub 2007. PMID: 17505013.
Chen J, Sen S, Amos CI, Wei C, Jones JS, Lynch P, Frazier ML. Association between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Mol Carcinog 46(4):249-56, 2007. e-Pub 2007.
Shi Y, Reiman T, Li W, Maxwell CA, Sen S, Pilarski L, Daniels TR, Penichet ML, Feldman R, Lichtenstein A. Targeting aurora kinases as therapy in multiple myeloma. Blood 109:3915-3921, 2007. e-Pub 2007.
Hu Q, Lu JF, Luo R, Sen S, Maity SN. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle. Nucleic Acids Res 34:6272-85, 2007. e-Pub 2007.
Carter JL, Li J, Sen S. Genomic and expression array profiling of chromosome 20q amplicon in human colon cancer cells. Human Genetics 11:128-134, 2005. e-Pub 2005.
Hu W, Kavanagh JJ, Deaver M, Johnston DA, Freedman RS, Verschraegen CF, Sen S. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Oncol Res 15(1):49-57, 2005. e-Pub 2005.
Sasai K, Katayama H, Stenoien DL, Fujii S, Honda R, Kimura M, Okano Y, Tatsuka M, Suzuki F, Nigg EA, Earnshaw WC, Brinkley WR, Sen S. Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motil Cytoskeleton 59(4):249-63, 2004. e-Pub 2004. PMID: 15499654.
Fraizer GC, Diaz MF, Lee IL, Grossman HB, Sen S. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol 25(6):1631-9, 2004. e-Pub 2004.
Ouchi M, Fujiuchi N, Sasai K, Katayama H, Minamishima YA, Ongusaha PP, Deng C, Sen S, Lee SW, Ouchi T. BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition. J Biol Chem 279(19):19643-8, 2004. e-Pub 2004. PMID: 14990569.
Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA, Sen S. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36(1):55-62, 2004. e-Pub 2004. PMID: 14702041.
Royce ME, Xia W, Sahin AA, Katayama H, Johnston DA, Hortobagyi G, Sen S, Hung MC. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis. Cancer 100(1):12-9, 2004. e-Pub 2004.
Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, Lippman SM. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev 12(12):1518-22, 2003. e-Pub 2003.
Katayama H, Brinkley WR, Sen S. Aurora kinase-A regulates kinetochore/chromatin associated microtubule assembly in human cells. Cancer Metastasis Rev 22(3):451-464, 2003. e-Pub 2003.
Stenoien DL, Sen S, Mancini MA, Brinkley BR. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle. Cell Motil Cytoskeleton 55:134-46, 2003. e-Pub 2003.
Mayer F, Stoop H, Sen S, Bokemeyer C, Oosterhuis JW, Looijenga LH. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes. Oncogene 22:3859-66, 2003. e-Pub 2003.
Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 9:991-7, 2003. e-Pub 2003.
Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, Katz RL, Brinkley W, Czerniak B. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94:1320-9, 2002. e-Pub 2002.
Li F, Adam L, Vadlamudi RK, Zhou H, Sen S, Chernoff J, Mandal M, Kumar R. p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep 3:767-73, 2002. e-Pub 2002.
Crosio C, Fimia GM, Loury R, Kimura M, Okano Y, Zhou H, Sen S, Allis CD, Sassone-Corsi P. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol 22:874-85, 2002. e-Pub 2002.
Katayama H, Zhou H, Li Q, Tatsuka M, Sen S. Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. J Biol Chem 276(49):46219-24, 2001. e-Pub 2001.
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20(2):189-93, 1998. e-Pub 1998.
Kuo MT, Sen S, Teeter L, Cailleau RM, Knesek JE, Bowen J. Expression of endogenous murine leukemia virus in transplantable tumor cells and DNA methylation of the viral sequences. Cancer Res 44:3518-21, 1984. e-Pub 1984.
Balasenthil S, Wang J, Chen J, Srivastava V, Rinaudo JA, Frazier ML, Sen S, Killary AM. Detection of Asymptomatic Pancreatic Adenocarcinoma using Blood-Based Biomarker Panel.

Invited Articles

Katayama H, Sen S. Aurora Kinase inhibitors as Anticancer Molecules. Biochim Biophys Acta 1799(10-12):829-39, 2010. e-Pub 2010. PMID: 20863917.
Sen S. Aurora-C Joins "The Three (Aurora Kinase) Tenors of Mitotic Symphony". Cell Cycle (News & Views), 2009. e-Pub 2009.
Sen S. Aneuploidy. Encyclopedia of Cancer, 2nd Edition, Springer Verlag, Berlin Heidelberg:158-164, 2008. e-Pub 2008.
Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22(4):451-64, 2003. e-Pub 2003. PMID: 12884918.
Sen S. Aneuploidy and cancer. Curr Opin Oncol 12(1):82-8, 2000. e-Pub 2000. PMID: 10687734.

Review Articles

Enriquez JS, Chu Y, Pudakalakatti S, Hsieh KL, Salmon D, Dutta P, Millward NZ, Lurie E, Millward S, McAllister F, Maitra A, Sen S, Killary A, Zhang J, Jiang X, Bhattacharya PK, Shams S. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer. JMIR Med Inform 9(6):e26601, 2021. e-Pub 2021. PMID: 34137725.
Kai K, Dittmar RL, Sen S. Secretory microRNAs as biomarkers of cancer. Semin Cell Dev Biol 78:22-36, 2018. e-Pub 2018. PMID: 29258963.
Barua S, Solis L, Parra ER, Uraoka N, Jiang M, Wang H, Rodriguez-Canales J, Wistuba I, Maitra A, Sen S, Rao A. A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. Cancer Inform 17:1176935118782880, 2018. e-Pub 2018. PMID: 30013304.
Wang J, Chen J, Sen S. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol 231(1):25-30, 2016. e-Pub 2016. PMID: 26031493.
Sasai K, Treekitkarnmongkol W, Kai K, Katayama H, Sen S. Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer. Front Oncol 6:247, 2016. e-Pub 2016. PMID: 27933271.
Sen S, Hopwood V. Molecular cytogenetic evidence for multistep tumorigenesis: implications for risk assessment and early detection. Cancer Biomark 9(1-6):113-32, 2010. e-Pub 2010. PMID: 22112472.
Sen S, Katayama H, Sasai K. Functional significance of Aurora Kinase A in Centrosome amplification and genomic instability. Adv Exp Med Biol 617:99-108, 2008. e-Pub 2008.
Kuo MT, Sen S, Hittelman WN, Hsu TC. Chromosomal fragile sites and DNA amplification in drug-resistant cells. Biochem Pharmacol 56:7-13, 1998. e-Pub 1998.

Abstracts

Dittmar R, Lo E, Duose D, Lampe P, Sen S. Early Genetic Changes in Pancreatic Cancer Cells Lead to Altered Exosomes Content. American Association for Cancer Pancreatic Cancer Advances in Science and Clinical Care, 2018. e-Pub 2018.
Kai K, Ladha F, Lu W, Yang F, Tang X, Wisstuba I, Sen S, Thompson A. SOX11 is a Potential Clinical Marker for Hormone Receptor Negative Subtype of Ductal Carcinoma in situ (DCIS). San Antonio Breast Cancer Symposium, 2018. e-Pub 2018.
Sen S. Genetics of Chromosome Segregation and Cancer. International Symposium on Development and Complex Disorders, Varanasi, India, 2012. e-Pub 2012.
Sen S. Aurora Kinase-A regulation of DNA damage response pathways in human cells. International Workshop on Ataxia Telangiectasia (ATW2012), New Delhi, India, 2012. e-Pub 2012.
Sen S. Aurora kinase regulation and VHL. 10th International VHL Medical Conference, Houston, Texas, 2012. e-Pub 2012.
Sen S. Profiling of microRNAs in Pancreatic Juice. 7th EDRN NCI-EDRN Scientific Workshop/23rd Steering Committee Meeting, Bethesda, MD, 2011. e-Pub 2011.
Sen S. MicroRNA deregulation in Pancreatic Cancer: From biology to development of biomarker signatures. NCI-EDRN Steering Committee Meeting, Los Angeles, CA, 2011. e-Pub 2011.
Sen S. Pathway targeting microRNA signagture as biomarkers of cancer. NCI, USA-ICMR, India Workshop on Translational Cancer Prevention and Biomarkers, Bangalore, India, 2011. e-Pub 2011.
Sen S. Aurora Kinase in Chromosomal Biology and Malignant Transformation. Third Meeting of the Asian Forum of Chromosome and Chromatin Biology: "Chromosome/Chromatin Dynamics, Epigenetics & Disease", Bangalore, India, 2010. e-Pub 2010.
Sen S, Killary AM, Frazier ML. Integrated functional genomic approach to biomarkers discovery. Twenty First EDRN Steering Committee Meeting, National Cancer Institute, Dallas, TX, 2010. e-Pub 2010.
Sen S. MicroRNA Functional Network in Pancreatic Cancer From Biology to Biomarkers. International Symposium on Functional Genomics, Varanasi, India, 2010. e-Pub 2010.
Sen S. Aurora-A-ER of regulatory interactions in human breast cancer cells. Sixth International Symposium on Hormonal Oncogenesis, Tokyo, Japan, 2010. e-Pub 2010.
Wang J, Katayama H, LeBlanc A, Frazier ML, Killary AM, Sen S. MicroRNA 301a elevated in pancreatic cancer targets tumor suppressor CDKN1A/p21 blocking cellular senescence and promoting invasion of pancreatic epithelial cells. American Association for Cancer Research 101st Annual Meeting, 2010. e-Pub 2010.
Katayama H, Wang J, Wang H, Jiang S, Wang H, Grizzle WE, Sen S. Aurora Kinase-A phosphorylation of p73 causes interaction of apoptosis and spindle assembly checkpoint responses pathways. American Association for Cancer Research 101st Annual Meeting, 2010. e-Pub 2010.
Sen S. Circulating microRNAs in plasma of pancreatic ductal adenocarcinoma patients as biomarkers of disease. EDRN Steering Committee Meeting of the National Cancer Institute - GI Collaborative Group, Bethesda, MD, 2009. e-Pub 2009.
Katayama H, Jiang S, Wang J, Leblanc A, Sen S. Emerging Evidence on the Role of Mitotic Regulatory Genes in Cancer. Indian Association of Cancer Research, Bangalore, India, 2009. e-Pub 2009.
Park HS, Park WS, Bondaruk J, Tanaka N, Katayama H, Lee S, Spiess PE, Steinberg JR, Wang Z, Katz RL, Dinney C, Lotan Y, Naeem RC, Baggerly K, Sen S, Grossman HB, Czerniak B. Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer. American Association for Cancer Research Annual Meeting, San Diego, CA, 2008. e-Pub 2008.
Park HS, Park WS, Bondaruk J, Tanaka N, Katayama H, Lee S, Spiess PE, Steinberg JR, Wang Z, Katz RL, Dinney C, Naeem RC, Baggerly K, Sen S, Grossman HB, Czerniak B. Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer. NCI Translational Science Meeting, Washington, DC, 2008. e-Pub 2008.
Sen S. Integrated genomic approach to developing biomarkers of pancreatic cancer. National Cancer Institute 18th Steering Committee Meeting, Seattle, WA, 2008. e-Pub 2008.
Park HS, Spiess PE, Tanaka N, Katayama H, Bondaruk J, Steinberg JR, Lee S, Wang Z, Dinney C, Baggerly K, Sen S, Grossman HB, Czerniak B. Aurora kinase A as a biomarker for the detection of bladder cancer. United States and Canadian Academy of Pathology Annual Meeting, Denver, C, 2008. e-Pub 2008.
Katayama H, Sasai K, Sen S. The Aurora Family of Kinases: A, B, C's of Mitosis in Human Cells. Aspen Cancer Conference, Aspen, CO, 2006. e-Pub 2006.
Spiess PE, Steinberg JR, Bondaruk J, Tanaka N, Lee S, Samanta S, Majewski T, Grossman HB, Sen S, Czerniak B. Aurora kinase A as a test for bladder cancer. American Association for Cancer Research Annual Meeting, Washington, DC, 2006. e-Pub 2006.
Steinberg JR, Spiess PE, Tanaka N, Bondaruk J, Tuziak T, Sen S, Czerniak B. Aurora A as a Novel Biomarker of Bladder Cancer. American Urological Association Annual Meeting, San Antonio, TX, 2005. e-Pub 2005.
Spiess PE, Steinberg JR, Tanaka N, Bondaruk J, Jeong J, Tuziak T, Grossman HB, Katz R, Sen S, Czerniak B. Aurora A: a biomarker of aneuploidy in bladder cancer. Gordon Conference, Buellton, CA, 2005. e-Pub 2005.
Sasai K, Katayama H, Nigg EA, Earnshaw WC, Sen S. A novel chromosomal passenger protein Aurora-A kinase can compliment Aurora-B kinase function and induce stabilization of INCENP via phosphorylation. American Association for Cancer Research Annual Meeting, Anaheim, CA, 2005. e-Pub 2005.
Steinberg JR, Tanaka N, Bondaruk J, Tuziak T, Sen S, Grossman HB, Czerniak B. Aurora A as a potential biomarker for bladder cancer. Employee Recognition Day, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004. e-Pub 2004.

Book Chapters

Dittmar R, Sen S. MicroRNAs in Exosomes in Cancer. In: Cancer and Noncoding RNAs (ed Chakrabarti J, Mitra S). Elsevier, 2017.
Sen S, Katayama H. In: Aurora Kinases In Targeted Therapy (ed Michael Andreeff). Springer, 2015.
Wang J, Sen S. In: MicroRNAs In Solid Tumors In Non-Coding RNAs and Cancer (ed Muller Fabbri). Springer, 45-65, 2014.
Wang J, Sen S. MicroRNAs in Solid Tumors. In: Non-coding RNAs and Cancer. Springer, 2013.
Sen S, Hopwood V. Molecular cytogenetic evidence for multistep tumorgenesis: Implications for risk assessment and early detection. In: Translational Pathology (ed Grizzle W, Srivastava S) IOS Press, The Netherlands, 2010.
Sen S, Katayama H, Sasai K. Functional Significance of Aurora Kinase A in Centrosome Amplification & Genomic Instability. In: Hormonal Carcinogenesis (ed. Li JJ, Li SA, Mohla S, Rochefort H, Maudelonde T), 99-108, 2008.
Sharma T, Cheong N, Sen P, Sen S. Constitutive heterochromatin and evolutionary divergence of Mus dunni, Mus booduga and Mus musculus. In: Current Topics in Microbiology and Immunology. Springer Verlag, 1986.

Less

CV information above last modified July 22, 2026

Subrata Sen, Ph.D.

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Abstracts

Book Chapters

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Subrata Sen, Ph.D.

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Abstracts

Book Chapters

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson